Amniotic Products Market to grow at a CAGR of 8.8% by 2031 | Organogenesis Inc., Integra LifeSciences, Stryker, Applied Biologics, Celularity, Inc., Katena Products, Inc.

New York, The amniotic products market was valued at $720 million in 2021 and it is anticipated to reach $1,680 million by 2031 at a CAGR of 8.8% during the forecast period (2022-2031).

Global Amniotic Products Market report from Global Insight Services is the single authoritative source of intelligence on Amniotic Products Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10237/

Amniotic fluid is the protective liquid enclosed by the amniotic membrane that serves as a cushion for the growing fetus and facilitates the exchange of nutrients, water, and biochemical products between mother and fetus. Amniotic-derived products, comprising amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that is being considered as a potential treatment option through augmentation of joint inflammation and healing.

Market Drivers
Growing incidence of burn injuries

The high incidence of the burn wound is likely to boost the growth of the market during the forecast period. According to WHO, an estimated 180,000 deaths every year are caused by burns-the high majority occur in low and middle-income economies. In India, over 1,000,000 people are moderately or severely burnt per year. Nearly 173,000 Bangladeshi children are moderately or severely burnt every year. Also, in Bangladesh, Colombia, Egypt, and Pakistan, 17% of children with burns have a temporary disability and 18% have a permanent disability.

Read more about Amniotic Products Market here: https://www.globalinsightservices.com/reports/amniotic-products-market/

Market Opportunity
Implementation of the 21st Century Cures Act (US)

The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation. The Act includes various provisions that may impact the development and approval of several products in the upcoming years. Under this Act, a new "Regenerative Medicine Advanced Therapy" designation has been established, along with a fast-track approval pathway for new regenerative medicine products and therapies. The implementation of this Act can potentially result in the approval of new regenerative medicine products and therapies in the US, as well as stimulate R&D activities in the field of regenerative medicine.

Market Segmental Analysis
The amniotic products market is segmented into type, application, and end user.

Global Amniotic Products Market by Application

By application, the global amniotic product market is segmented into wound care, orthopedics, ophthalmology, and others.

The wound care segment is likely to dominate the market. The key factors such as the growing incidence of ulcers, traumatic and surgical wounds, and burns and the need for advanced technologies for the treatment is likely to boost the growth of the market.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10237/

Global Amniotic Products Market by End User

By end-user, the global amniotic products is bifurcated into hospitals, clinics, home care, research institutes, academic, and others.

Geographical Analysis of Global Amniotic Products Market

The global amniotic products market is studied for key countries of the regions such as North America, Europe, Asia Pacific, and the Rest of the World.

North America is likely to dominate the market during the forecast period. The key factors such as the high prevalence of target diseases coupled with increasing geriatric populations, rising awareness about advanced treatment options, and the strong presence of key market players in the regions are boosting the growth of the market in the region.

Market Players of Global Amniotic Products Market
The key players in the global amniotic products market is MiMedx, Smith & Nephew, Organogenesis Inc., Integra LifeSciences, Stryker, Applied Biologics, Celularity, Inc., Katena Products, Inc., Lucina BioSciences, Next Biosciences, Skye Biologics Holdings, LLC, Surgenex, TissueTech, Inc., Ventris Medical, LLC, StimLabs LLC, VIVEX Biologics, Inc., LifeCell International Pvt. Ltd., NuVision Biotherapies Ltd., Genesis Biologics, Surgilogix, Tides Medical, Orthofix Medical Inc., AlloSource, Merakris Therapeutics, and MTF Biologics among others.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10237/

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.